Literature DB >> 2918924

Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds).

G H Travis1, M B Brennan, P E Danielson, C A Kozak, J G Sutcliffe.   

Abstract

Mutant mice homozygous for 'retinal degeneration slow' (rds/rds) are characterized phenotypically by abnormal development of photoreceptor outer segments in the retina, followed by gradual degeneration of photoreceptors. This process of degeneration is complete by one year, with preservation of all other retinal cells. The biochemical defect that leads to the mutant phenotype is not known. Our strategy for cloning the rds gene was based upon three previously reported observations. First, the rds locus maps to chromosome 17. Second, experimental rds/rds----+/+ and rds/+----+/+ tetra-parental mice manifest patchy photoreceptor changes in the retina, suggesting that the wild-type rds locus is expressed within cells of the photoreceptor lineage. Finally, the process of degeneration is specific to photoreceptors. On the basis of these observations, we predicted that the rds mRNA is encoded by a gene on chromosome 17 and is normally expressed exclusively within photoreceptors in the retina. We here present evidence that this is the case.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2918924     DOI: 10.1038/338070a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  93 in total

Review 1.  Molecular ophthalmology: an update on animal models for retinal degenerations and dystrophies.

Authors:  F Hafezi; C Grimm; B C Simmen; A Wenzel; C E Remé
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

Review 2.  Open-system approaches to gene expression in the CNS.

Authors:  J G Sutcliffe
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 3.  Photoreceptor renewal: a role for peripherin/rds.

Authors:  Kathleen Boesze-Battaglia; Andrew F X Goldberg
Journal:  Int Rev Cytol       Date:  2002

4.  The L6 membrane proteins--a new four-transmembrane superfamily.

Authors:  M D Wright; J Ni; G B Rudy
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

5.  RDS/peripherin gene mutations are frequent causes of central retinal dystrophies.

Authors:  S Kohl; M Christ-Adler; E Apfelstedt-Sylla; U Kellner; A Eckstein; E Zrenner; B Wissinger
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

6.  In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse.

Authors:  Bo Chang; Hemant Khanna; Norman Hawes; David Jimeno; Shirley He; Concepcion Lillo; Sunil K Parapuram; Hong Cheng; Alison Scott; Ron E Hurd; John A Sayer; Edgar A Otto; Massimo Attanasio; John F O'Toole; Genglin Jin; Chengchao Shou; Friedhelm Hildebrandt; David S Williams; John R Heckenlively; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2006-04-21       Impact factor: 6.150

7.  Chromosomal localization of the murine genes for the alpha- and beta-subunits of calcium/calmodulin-dependent protein kinase II.

Authors:  M Danciger; C A Kozak; M C Adamson; D B Farber
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

8.  Characterization of mice lacking the tetraspanin superfamily member CD151.

Authors:  Mark D Wright; Sean M Geary; Stephen Fitter; Gregory W Moseley; Lai-Man Lau; Kuo-Ching Sheng; Vasso Apostolopoulos; Edouard G Stanley; Denise E Jackson; Leonie K Ashman
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 9.  AAV-mediated gene therapy in mouse models of recessive retinal degeneration.

Authors:  J-J Pang; L Lei; X Dai; W Shi; X Liu; A Dinculescu; J H McDowell
Journal:  Curr Mol Med       Date:  2012-03       Impact factor: 2.222

10.  Intracisternal A-type particle elements as genetic markers: detection by repeat element viral element amplified locus-PCR.

Authors:  N Kaushik; J P Stoye
Journal:  Mamm Genome       Date:  1994-11       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.